COVID-19

The impact of high breathing efforts on the lungs of patients suffering with acute respiratory failure due to the novel coronavirus (COVID-19) has

Antibody levels remain high nine months after infection with SARS-CoV-2, the virus that causes the novel coronavirus (COVID-19), whether symptomatic

The U.S. Food and Drug Administration announced this week revisions to the vaccine recipient and vaccination provider fact sheets for the Johnson

The companies behind one of the three novel coronavirus (COVID-19) vaccinations authorized for emergency use, Pfizer and BioNTech, met with health

A survey offered to transgender and nonbinary people across six continents and in thirteen languages shows that during the first months of the novel

In a new study published in the journal PLOS Medicine, researchers from the University of Sydney looked at how the immune system responds to the

People with the novel coronavirus (COVID-19) may experience milder symptoms if certain cells of their immune systems "remember" previous encounters

Two doses of the inactivated novel coronavirus (COVID-19) vaccine, CoronaVac, manufactured by Sinovac, are safe and provoke a strong antibody